LATS1 and chronic myelogenous leukemia, BCR-ABL1 positive: Consistent with mRNA levels, higher levels of LATS1 and LATS2 proteins were observed in 10 randomly selected IM-resistant CML patients compared to healthy donors (Fig. 1C).